These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25461526)

  • 1. Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability.
    Holinka LG; Fernandez-Sainz I; Sanford B; O'Donnell V; Gladue DP; Carlson J; Lu Z; Risatti GR; Borca MV
    Virology; 2014 Dec; 471-473():13-8. PubMed ID: 25461526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a live attenuated antigenic marker classical swine fever vaccine.
    Holinka LG; Fernandez-Sainz I; O'Donnell V; Prarat MV; Gladue DP; Lu Z; Risatti GR; Borca MV
    Virology; 2009 Feb; 384(1):106-13. PubMed ID: 19046591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of classical swine fever control: modified live and E2 subunit vaccines.
    Huang YL; Deng MC; Wang FI; Huang CC; Chang CY
    Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
    Aebischer A; Müller M; Hofmann MA
    Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recoding structural glycoprotein E2 in classical swine fever virus (CSFV) produces complete virus attenuation in swine and protects infected animals against disease.
    Velazquez-Salinas L; Risatti GR; Holinka LG; O'Donnell V; Carlson J; Alfano M; Rodriguez LL; Carrillo C; Gladue DP; Borca MV
    Virology; 2016 Jul; 494():178-89. PubMed ID: 27110709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
    J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
    Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
    Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G.
    Holinka LG; O'Donnell V; Risatti GR; Azzinaro P; Arzt J; Stenfeldt C; Velazquez-Salinas L; Carlson J; Gladue DP; Borca MV
    PLoS One; 2017; 12(5):e0177433. PubMed ID: 28542321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marker vaccine strategies and candidate CSFV marker vaccines.
    Dong XN; Chen YH
    Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The double-antigen ELISA concept for early detection of E
    Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
    Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and Characterization of a Moderately Virulent Classical Swine Fever Virus Emerging in China.
    Luo Y; Ji S; Liu Y; Lei JL; Xia SL; Wang Y; Du ML; Shao L; Meng XY; Zhou M; Sun Y; Qiu HJ
    Transbound Emerg Dis; 2017 Dec; 64(6):1848-1857. PubMed ID: 27658930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.
    Muñoz-González S; Perez-Simó M; Muñoz M; Bohorquez JA; Rosell R; Summerfield A; Domingo M; Ruggli N; Ganges L
    Vet Res; 2015 Jul; 46(1):78. PubMed ID: 26159607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.
    Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA
    J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE
    Lim SI; Choe S; Kim KS; Jeoung HY; Cha RM; Park GS; Shin J; Park GN; Cho IS; Song JY; Hyun BH; Park BK; An DJ
    Vaccine; 2019 Jun; 37(27):3598-3604. PubMed ID: 31151802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
    Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
    Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate.
    Tong C; Liu H; Wang J; Sun Y; Chen N
    Vaccine; 2022 Nov; 40(50):7219-7229. PubMed ID: 36328881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.